Chicago is that “toddling town,” according to the immortal croonings of Frank Sinatra. It’s also set to become “endocrine central” when ENDO 2026 arrives June 13 – 16. Spread out along the shoreline of Lake Michigan, the Windy City is a quintessential American metropolis, with iconic skyscrapers, beautiful parks, charming neighborhoods, fabulous restaurants, and one...
A significant retrospective cohort study has revealed that even mild levels of glucose intolerance during pregnancy are associated with a higher risk of obesity in children as they reach adolescence. The research, published in The Journal of Clinical Endocrinology & Metabolism, suggests that the in utero environment may play a more critical role in long-term...
Researchers have identified a specific set of biological markers in the blood that can predict the onset of dangerous arterial plaques in people living with HIV years before it becomes visible on a scan. The study, “Inflammation-associated Lipidomic Signatures Prior to Carotid Artery Atherosclerosis in People Living With HIV,” published in The Journal of Clinical...
Marcus D. Goncalves, MD, PhD, has been appointed director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. He succeeds Ira J. Goldberg, MD, who has led the division since 2014 and will continue as a member of the faculty. Goncalves joined NYU Langone in 2024 from Weill Cornell Medicine and New York-Presbyterian Hospital....
Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding Last month, Congress finally passed a funding bill for the Department of Health & Human Services for fiscal year (FY) 2026. The bill includes an increase of about $415 million for the National Institutes of Health (NIH), including a $10 million increase for diabetes research, and language the Endocrine Society had advocated for to protect the NIH by limiting a budget...
On behalf of the Endocrine Society’s Early-Career Special Interest Group, Maria Andrea Camilletti, PhD, takes us on a guided journey from family influences to how she developed such a keen interest in the pituitary, and explains why it brings her so much joy. As a child, I knew I wanted to be a scientist without...
Obviously, from that headline I’m referring to GLP-1s and their many similar glucagon-like peptide-1 receptor agonist cohorts that have become a medical, healthcare, and even cultural zeitgeist over the course of the last couple of years. In fact, I bet every single person reading these words can sing the Ozempic jingle right now! This month’s...
The Endocrine Society’s 2026 recipient of the Outstanding Clinical Investigator Laureate Award, Samuel Klein, MD, has spent the better part of the last 30 years researching why obesity affects people differently. He talks to Endocrine News about this perplexing dilemma and how he hopes his research could one day help solve this puzzle. For more...
Obviously, from that headline I’m referring to GLP-1s and their many similar glucagon-like peptide-1 receptor agonist cohorts that have become a medical, healthcare, and even cultural zeitgeist over the course of the last couple of years. In fact, I bet every single person reading these words can sing the Ozempic jingle right now! This month’s...
